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Abstract
Background: Angiotensin II (AII) effects on intestinal Na+ transport may be multifactorial. To
determine if AII might have a direct effect on intestinal epithelial Na+ transport, we investigated its
actions on Na+ transport in human intestinal epithelial Caco2BBE cells.
Results: AII increased apical (brush border) sodium-hydrogen exchanger (NHE)-3, but not NHE2,
activity within one hour. Similarly, only apical membrane NHE3 abundance increased at 1–2 hours
without any change in total NHE3 protein abundance. From 4–48 hours, AII stimulated
progressively larger increases in apical NHE3 activity and surface abundance, which was associated
with increases in NHE3 protein expression. At 4–24 hours, NHE3 mRNA increases over baseline
expression, suggesting increased gene transcription. This was supported by AII induced increases
in rat NHE3 gene promoter-reporter activity. AII induction of NHE3 was blocked by the AII type
I receptor antagonist losartan. Acute changes in AII-induced increases in NHE3 exocytosis were
blocked by a phospholipase C inhibitor, an arachidonic acid cytochrome P450 epoxygenase
inhibitor, as well as phosphatidylinositol 3 kinase (PI3K) inhibitors and Akt inhibitor, partially
blocked by a metalloproteinase inhibitor and an EGF (epidermal growth factor) receptor kinase
inhibitor, but not affected by an inhibitor of MEK-1 (MAPKK-1, mitogen activated protein kinase
kinase-1).
Conclusion: We conclude that angiotensin II has a direct role in regulating intestinal fluid and
electrolyte absorption which may contribute to its overall effects in regulation systemic volume and
blood pressure. AII activates several key signaling pathways that induce acute and chronic changes
in NHE3 membrane trafficking and gene transcription.
Background
The octapeptide angiotensin II (AII) has diverse effects
and regulates organismal blood pressure through many
mechanisms, including effects on renal and intestinal
fluid and electrolyte transport and changes in vascular
smooth muscle tone. Through these mechanisms, AII
increases plasma volume and vasoconstriction, which
contribute to its effect on blood pressure. In the kidney, in
addition to stimulation of Na+  reabsorption through
increasing aldosterone release, AII also increases Na+
transport at the proximal convoluted tubule through
direct stimulation of apical sodium/hydrogen exchanger
(NHE) activity [1-4], in part mediated by direct action on
proximal tubular AII receptors [5-8]. In the GI tract, AII
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increases activity and expression of colonic electrogenic
Na+ channels [9,10], small intestinal electroneutral Na+
absorption [11-13], modulates colonic K+ transport [14],
and may also induce HCO3- secretion [15-17]. However
the precise mechanism(s) underlying these effects remain
incompletely understood. For some studies, the effects of
AII on transport have been introduced vascularly [11,12]
and therefore the effects could be direct or indirect, such
as AII-induced alterations of enteric nervous control of
ion transport or alterations of regional blood flow. Aldos-
terone is also thought to be involved in AII-induced
sodium absorption in the GI tract, which targets the epi-
thelial sodium channel [12]. However, AII binding sites
have been demonstrated in membranes from intestinal
epithelial cells [18] and AII affects growth and prolifera-
tion of cultured small intestinal epithelial cells [19-21],
suggesting direct intestinal effect of AII.
The present studies demonstrate that AII increases, in an
aldosterone independent fashion, activity and expression
of the apical sodium/hydrogen exchanger NHE3, but not
NHE2, in cultured Caco2BBE cells. Because apical mem-
brane NHEs of the intestine are the major mediators of
non-nutrient dependent absorption of Na+ [22,23], these
effects can potentially contribute to overall maintenance
of metabolic balance and blood presssure. These effects
are mediated by type I AII receptors through pathways
that are dependent on phospholipase C, epoxygenase
metabolism of arachidonic acid, phosphatidyl inositol 3
kinase and Akt, and partially on metalloproteinase activ-
ity and stimulation of the EGF receptor. These studies
therefore provide compelling evidence of direct regula-
tion of apical NHE3 in intestinal epithelial cells by AII.
Results
Angiotensin II increases NHE3, but not NHE2, activity and 
membrane insertion acutely and in long term
Caco2BBE cell monolayers were treated on the basolateral
side with 1 nM angiotensin II for times ranging from 1–48
hours. Apical NHE activities were measured as 22Na+
uptake sensitive to amiloride analogs HOE694 (30 μM to
inhibit NHE2) or DMA (500 μM to inhibit both NHE3
and NHE2), as previously described [24]. NHE2 and
NHE3 activities were defined as the HOE694-sensitive
and -insensitive components of DMA-inhibited 22Na
uptake, respectively. After two hours, 1 nM angiotensin II
significantly increased apical NHE3, but not NHE2 activ-
ity (Figure 1A, left panel). The increased NHE3 activity
was paralleled by increased apical surface abundance of
NHE3, as assessed by apical surface biotinylation (Figure
1A right panel). In previous studies [25] we had demon-
strated that the conditions for apical surface biotinylation
do not result in biotinylation of either basolateral surface
proteins or intracellular proteins. Equivalent protein
amounts (500 μg) were used for apical surface biotinyla-
tion and total NHE analyses (50 μg). Apical addition of 1
nM AII did not stimulate apical 22Na+ transport at any
time up to 48 hours (data not shown). Further increases
in apical NHE3 activity were observed between 4–48
hours after AII stimulation, occurring in two 'phases'.
From 1–4 hours, a smaller increase in apical NHE3 activ-
ity was observed with a progressive increase from 4 to 24
hours that was maintained for at least 24 hours. These
changes were associated with increased apical surface
NHE3 abundance. Within one hour, however, little
increase in total NHE3 protein expression was observed
and from 2–48 hours, NHE3 protein expression increased
(Figure 1A). No changes were observed for apical surface
or total NHE2 over this time (Figure 1A). AII increased
NHE3 expression and activity at 24 hours in a concentra-
tion-dependent fashion with effects beginning at low pM
concentrations and maximal effects near 1 nM, concentra-
tions that are in the physiologic range (Figure 1B).
To determine if AII stimulates Na+ transport in native
intestine, segments of mouse jejunum were mounted in
Ussing chambers and transmural 22Na+ fluxes measured.
Addition of AII (added 15 min serosally before initiation
of flux period) significantly increased the mucosal to sero-
sal absorptive flux without change in the seriosal to
mucosal flux, demonstrating that the AII-induced apical
NHE3 activity observed in cultured Caco2BBE cells is also
observed in native intestine (Figure 2). The increase in m-
to-s flux is small, however, it should be noted that the
incubations time with AII was limited due to the limited
viability of mouse jejunum in Ussing chambers. AII was
therefore added approximately 10 min after mounting tis-
sues in the chambers and allowed to incubate with the
mucosal strip for 15 min before initiating the 30 min flux
period. Had the experimental conditions allowed longer
incubations, we suspect that the AII effect would have
been greater.
AII stimulates transcription of the NHE3 gene
To determine whether AII increased NHE3 transcription-
ally, mRNA levels for NHE3 were measured by real time
PCR. AII increased NHE3 mRNA as early as 2 hours after
treatment and this effect was maximal at 12 hours (Figure
3). To determine that the mRNA increase was indeed due
to increased transcription and not message stabilization,
luciferase reporter assays with a 2200 bp segment of the
rat NHE3 gene promoter linked to firefly luciferase was
used [26]. AII increased luciferase activity in a concentra-
tion dependent manner (Figure 3B), demonstrating that
AII promoted NHE3 gene transcription.
AII stimulation of NHE3 employs the type I receptor
To determine which type AII receptors were expressed by
Caco2BBE cells, mRNA was isolated and primers specific
to the type I and II receptors were used for RT-PCR analy-BMC Physiology 2009, 9:5 http://www.biomedcentral.com/1472-6793/9/5
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ses. Both types of receptors were expressed by these cells
(Figure 4A). To confirm that the PCR products were type I
and II human AII receptors, PCR bands were subcloned
and sequenced. Sequence of these PCR products was iden-
tical to the gene sequences, confirming expression of both
receptor types. Therefore, to determine whether the acute
stimulation of NHE3 by AII used the type I or II receptor,
the receptor blockers losartan(type I) and PD123319
(type II) were used. Inhibition of type I but not type II
receptors inhibited the AII stimulated apical Na+ influx
(Figure 4B) as well as AII stimulated exocytosis of NHE3
(Figure 4C).
To determine the mechanism of action, a panel of inhibi-
tors were used for pathways known to be activated by AII
or other G protein coupled receptors [20,21,27]. The fol-
lowing panel of inhibitors were tested: U73122, a phos-
pholipase C inhibitor; ketoconazole, a cytochrome P450
inhibitor which blocks fatty acid epoxygenation; TAPI-1, a
metalloproteinase inhibitor; tyrphostin AG-1478, an EGF
receptor tyrosine kinase inhibitor; PD98059, a MEK-1
inhibitor; wortmannin and LY294002, phosphatidyl
inositol 3 kinase inhibitors, and API-9, an Akt inhibitor.
Angiotensin II increases NHE3 but not NHE2 in Caco2BBE cells Figure 1
Angiotensin II increases NHE3 but not NHE2 in Caco2BBE cells. (A) Monolayers were treated basolaterally with (A) 
1 nM AII for varying times or (B) varying concentrations of AII for 48 hours. Apical NHE2 and NHE3 activities were measured 
as described in Materials and Methods. Apical surface NHE3 and NHE2 were measured using apical surface biotinylation. Total 
NHE expression was measured in whole lysates. Fluxes and images are representative of four separate experiments. Flux val-
ues are means ± SEM. Densitometric values were calculated setting intensity for the zero time value (A) or no addition (B) to 
100% in each experiment and calculating densitometric changes (decreases or increases) of other groups relative to these val-
ues. * P < 0.05 + P < 0.01 compared with untreated zero time control by analysis of variance using a Bonferroni correction.
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All of these agents except PD98059 inhibited the AII stim-
ulation of NHE3 activity after 1 hour (Figure 4B), effects
that were paralleled by their effects on AII stimulated api-
cal surface NHE3 (Figure 4C).
To determine if the long term changes in NHE3 expres-
sion were also mediated by type I receptor stimulation,
cells were pretreated with losartan or PD123319 and stim-
ulated with AII for 24 hours and Na+ fluxes measured.
Inhibition of the type I receptor blocked the AII-stimu-
lated Na+ flux increase while PD123319 had no effect
(fluxes for each condition in nmoles/10 min-Transwell, n
= 4, means ± SEM: no addition 4.08 ± 0.33, AII (1 nM)
6.59 ± 0.68, losartan + AII 4.29 ± 0.54, and PD123319 +
AII 6.36 ± 0.79). Therefore the long term effects of AII on
Caco2BBE NHE3 are also mediated by type I receptor
stimulation.
Discussion
The role of AII in regulation of blood pressure is well
established, however, its actions are likely to occur
through multiple mechanisms including effects on vascu-
lar smooth muscle and endothelium [28,29]. AII can also
affect salt and water homeostasis through its actions on
renal Na reabsorption [1,30]. In addition, AII stimulates
aldosterone production by the adrenal gland that is a
major regulator of renal and intestinal Na+ transport [31].
The present studies demonstrate that AII has direct effects
on intestinal epithelial Na+ transport that are consistent
with its desired effect to increase fluid absorption.
Although AII has been noted to increase small intestinal
Na+ absorption previously [11,13], the present studies
provide a more definitive analysis, demonstrating that
this is due to stimulated exocytosis of the apical trans-
porter NHE3 and later increased expression of this trans-
porter. In contrast, NHE2 activity is not regulated by AII.
NHE2 has a lesser contribution to intestinal Na+ transport
Angiotensin II stimulates absorptive Na+ flux in mouse jeju- num Figure 2
Angiotensin II stimulates absorptive Na+ flux in 
mouse jejunum. Sections of mouse jejunum were mounted 
in Ussing chambers and matched for transepithelial electrical 
resistance (differed by less than 20%). One set was treated 
with 1 nM AII on the serosal side and mucosal (m) to serosal 
(s) and s-to-m fluxes measured over the next 30 min. Values 
are means ± SEM for six separate experiments. * p < 0.05 
compared with untreated tissues by paired Student's T test.
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Angiotensin II increases NHE3 gene transcription. (A) 
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varying times and RNA harvested and analyzed for NHE3 
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transfected with plasmids containing a 2200 bp segment of 
the rat NHE3 gene promoter linked to firefly luciferase 
cDNA and another with the thymidine kinase promoter 
linked to Renilla luciferase as a constitutive control. Cells 
were treated with AII (0–1 μM) 24 hours after transfection 
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[32] and is regulated differently by agonist-activated sec-
ond messenger pathways [24].
The actions of AII on intestinal epithelial Na transport
appear to involve both acute and chronic effects. Acutely,
AII rapidly stimulates insertion of NHE3 into the apical
membrane which increases Na+  absorption. However,
over time, AII stimulates transcriptional activation of the
NHE3 gene, resulting in increases in total NHE3 protein
abundance. This second phase is associated with addi-
tional apical membrane insertion of NHE3 and enhanced
Na absorptive capacity. The effects of AII on intestinal
transport could be either indirect and/or direct and the
present studies demonstrate that direct effects occur.
When AII was given intravascularly, it stimulated the
enteric nervous system which could affect intestinal elec-
trolyte transport [11,12]. However, when AII was added to
in vitro preparations of rat small intestine serosally, it stim-
ulated Na+  transport, suggesting that AII was acting
directly on epithelial cells [13] similar to present results in
mouse jejunum. Adding further support to this possibil-
ity, AII binds with high affinity to intestinal enterocyte
membranes [18,33]. More recent studies of porcine jeju-
num found both types of the AII receptor, however full
thickness intestine was used for analysis which contains
both epithelial and non-epithelial cell components [15].
Luminal/brush border type I and II AII receptors have
been functionally demonstrated in intestine where lumi-
nal AII, through the type I receptor, inhibits apical Na+-
dependent glucose transport [33]. A similar finding of
brush border type I AII receptor regulates apical glucose
uptake in LLC-PK porcine kidney cells [34]. The effects on
apical sodium transport were not measured in these stud-
ies of intestinal and renal brush border membranes.
The intestine possesses a complete renin-angiotensin sys-
tem [35] that appears to have local autocrine and para-
crine effects [36]. Angiotensinogen, renin and the
angiotensin converting enzyme are all expressed in the
intestine, as well as both types of AII receptors [35,37-39].
From the present studies, we cannot determine the role of
systemic versus locally produced AII. Indeed, regulation of
these 'local' renin-angiotensin systems has received mod-
est investigation. In the intestine, activity of the Na+-
dependent glucose transporter, but not leucine trans-
porter, was decreased by AII, an effect that may be related
to its effects on the brush border [33].
The present studies strongly support the type I receptor as
the mediator of the AII effects on the acute stimulation of
NHE3. The signal transduction pathways of the type I AII
receptor are complex and involve multiple pathways. In a
cultured small intestinal cell line, IEC-6, AII stimulates
several transduction pathways including phospholipase
D, certain isoforms of protein kinase C, and activation of
the EGF receptor [19-21] that stimulate cell growth.
Conclusion
AII can directly stimulate intestinal epithelial Na+ absorp-
tion through the AII-receptor activation of several key sig-
naling pathways that induce acute and chronic changes in
NHE3 membrane trafficking and gene transcription.
These processes involve rapid exocytosis of the major
Type I AII receptors mediate AII effects on NHE3 through  activation of phospholipase C, epoxygenation of arachidonic  acid, stimulation of the EGF receptor, and activation of phos- phatidyl inositol 3 kinase and Akt Figure 4
Type I AII receptors mediate AII effects on NHE3 
through activation of phospholipase C, epoxygena-
tion of arachidonic acid, stimulation of the EGF 
receptor, and activation of phosphatidyl inositol 3 
kinase and Akt. (A) RNA was harvested from a cell monol-
ayer, reverse transcribed, and analyzed for AII type I and II 
receptors by PCR. (B) To determine the mechanism of 
action of AII, cell monolayers were treated basolaterally with 
the type I receptor antagonist losartan (100 μM) or the type 
II receptor antagonist PD123319 (100 μM) or with inhibitors 
of phosholipase C (U73122, 30 μM), cytochrome P450 fatty 
acid epoxygenase (ketoconazole, 30 μM), a metalloprotein-
ase inhibitor (TAPI-1, 100 μM), EGF receptor tyrosine kinase 
(Tyrphostin AG1478, 30 μM), MEK-1 (PD98059, 30 μM), 
phosphatidyl inositol 3 kinase (wortmannin, 30 μM or 
LY294002, 30 μM), Akt (API-1, 30 μM) all for 30 min prior to 
addition of AII (1 nM). Fluxes were measured 1 hr after baso-
lateral addition of AII. Values are means ± SEM for four sepa-
rate experiments. * P < 0.05 + P < 0.01 as designed for 
comparisons by analysis of variance using a Bonferroni cor-
rection. (C) Cells were treated as for flux studies in B, how-
ever, cells were used for apical surface biotinylation as 
described in Methods. Image shown is representative of 
those of four separate experiments. Densitometric values 
were calculated by setting the intensity for no addition to 
100% in each experiment and calculating densitometric 
changes of other groups (decreases or increases) relative to 
this value. Values are means ± SE. * P < 0.05 + P < 0.01 as 
designed for comparisons by analysis of variance using a Bon-
ferroni correction.
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non-nutrient Na+ absorptive pathway, NHE3 via activa-
tion of the type I receptor and activation of complex trans-
duction pathways. AII does not, however, stimulate
exocytosis and activity of the related exchanger NHE2. AII
activation of the intestinal epithelial cells also has more
prolonged effects on fluid and electrolyte absorption and
homeostasis as expression of the exchanger NHE3 is
increased. We conclude that angiotensin II has a direct
role in regulating intestinal fluid and electrolyte absorp-
tion which may contribute to its overall effects in regula-
tion systemic volume and blood pressure.
Methods
Cell Culture
Caco-2BBE intestinal epithelial cells, provided by Dr.
Mark Mooseker [40](Yale University, New Haven, CT),
were grown as confluent monolayers on rat tail collagen-
coated Transwells in DMEM supplemented with 10% vol/
vol fetal bovine serum, 2 mM glutamine, 10 μg/ml trans-
ferrin, 50 U/ml penicillin, and 50 μg/ml streptomycin in
a humidified atmosphere of air containing 5% CO2. Cells
were seeded onto the collagen coated Transwells at a den-
sity of 105 cells/cm2 and cultured for 14 days before each
experiment. Differentiation of Caco-2BBE cells in culture
was determined by expression of villin and alkaline phos-
phatase.
Apical membrane unidirectional 22Na+ influx as a measure 
of Na+-H+ exchange (NHE) activity
For influx studies, Caco2BBE cell monolayers were
washed once in 150 mM choline Cl, 10 mM HEPES pH
7.4 and then unidirectional apical membrane sodium
uptakes were determined in flux buffer (130 mM Choline
Cl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 15 mM HEPES
pH 7.4, 20 mM NaCl with 1 μCi/ml [22NaCl]) for ten min-
utes. Sodium influx was stopped by 4 washes in cold
buffer (140 mM NaCl, 5 mM KCl, 15 mM HEPES pH 7.4
and 1 mM Na3PO4) and was calculated by dividing the
accumulated DPM by the specific Na activity in the
medium. Dimethylamiloride (DMA) (500 μM) and HOE
694 (30 μM) were used to distinguish NHE2 and NHE3
activities, as previously described [24]. NHE2 and NHE3
activities were defined as the HOE694-sensitive and -
insensitive components of total DMA-inhibited unidirec-
tional 22Na influx, respectively.
For studies on apical NHE3 exocytosis, cell monolayers
were stimulated with AII for varying times with or without
pretreatment with inhibitors as designated. AII was added
directly into the basolateral medium. Monolayers were
rapidly cooled by placing on ice, changing medium to
phosphate buffered saline with 0.5 mg/ml sulfo-NHS
biotin only on the apical side. Monolayers were incubated
for 30 min with the apical biotinylation solution. Over
this period, we had previously shown that biotinylation of
basolateral and intracellular proteins does not occur [25].
Biontinylation was terminated by the addition of 10 μl of
1 M Tris pH 8.0 which will reacts rapidly with all free
biotin. Cell monolayers were scraped off the filters, pel-
leted and resuspended in immunoprecipitation buffer (IP
buffer, composition in mmol/l:150 NaCl, 10 HEPES pH
7.4, 2 EDTA, 1 PMSF, 0.1% SDS 0.5% deoxycholate (both
wt/vol) and 1% Triton X-100 (vol/vol)). Samples were
solubilized, an aliquot removed to measure protein and
total NHE3, and, to the remainder. streptavidin-agarose
was added. Samples were rotated for 120 min, washed 3
times with IP buffer, and samples eluted by boiling in 1×
Laemmli buffer. Biotinylated apical surface proteins as
well as total NHE3 were analyzed by Western blotting.
Total cellular protein (35 μg) or IP samples were separated
on 7.5% SDS-PAGE and immediately transferred to PVDF
membranes (Polyscreen, Perkin Elmer Life Sciences, Bos-
ton, MA) in 1× Towbin's buffer (25 mM Tris, 192 mM gly-
cine, pH 8.8 with 15% vol/vol methanol). Membranes
were blocked in T-TBS (Tween 20-Tris buffered saline; 150
mM NaCl, 5 mM KCl, 10 mM Tris pH 7.2 with 0.1% vol/
vol Tween 20) containing 5% wt/vol nonfat dry milk
(Carnation, Solon, OH) for 60 min at room temp. Blots
were incubated overnight at 4°C with affinity purified
specific rabbit polyclonal antisera to NHE2 and NHE3
developed and characterized by our laboratory [41,42].
Blots were developed using an enhanced chemilumines-
cence system (Supersignal, Pierce Chemical, Rockford,
IL).
RNA isolation, reverse transcription, and real-time PCR
Caco-2BBE cells were treated with AII (1 nM) for varying
times. Total RNA was isolated using TRIzol reagent (Invit-
rogen). One μg RNA was reverse transcribed by random
priming (Superscript II RT, Invitrogen, Carlsbad, CA) and
one twentieth used for real-time PCR performed on an I
Cycler (BioRad, Hercules, CA) using SybrGreen Mix and
primers for human NHE3 (NM_004171, bases 2062–
2164 and GAPDH (NM_002046, bases 160–229). Rela-
tive mRNA levels were calculated using the comparative
threshold cycle (ΔΔCt) method [43]. Each PCR reaction
was performed in triplicate, and all experiments were
repeated three times. For each sample, mRNA levels of
both NHE3 and GAPDH were measured and the cycle
threshold of NHE3 subtracted from that of GAPDH. This
value was set to one for untreated control conditions at
zero time and other time points are calculated relative to
this change. For analysis of AII receptor type, one twenti-
eth of the reverse transcription reaction was used for
amplification with primers for human ATGR1
(NM_004835, bases 675–808) and AGTR2 (NM_000686,
bases 740–918). PCR reactions were amplified for 30BMC Physiology 2009, 9:5 http://www.biomedcentral.com/1472-6793/9/5
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cycles and the PCR products were first analyzed by agarose
gel for confirmation of correct size and then subcloned
into pCR2.1-TOPO (Invitrogen) and sequenced.
Luciferase reporter activity
A 2200 bp region of the rat NHE3 promoter [26] was a
generous gift of Dr. A. Cano (Univ. of Texas Southwestern
Medical Center, Dallas, TX). This promoter was linked to
firefly luciferase in the plasmid pGL3 (Promega, Madison,
WI). Monolayers were transiently transfected with 2 μg of
the NHE3 promoter-firefly luciferase plasmid along with
100 ng of a thymidine kinase promoter linked to Renilla
luciferase reporter plasmid using 10 μl of the transfection
reagent LT-1 (Mirus, Madison, WI) according to the man-
ufacturer's directions. Twenty four hours after transfec-
tion, monolayers were treated with AII. Cell monolayers
were harvested in lysis buffer provided with the dual-luci-
ferase assay kit and firefly and Renilla luciferase measured
in a Berthold Lumat luminometer (Berthold, NJ) using
the protocol provided with the Dual Luciferase assay sys-
tem (Promega, Madison, WI).
Statistical analysis and densitometry
For all statistical comparisons, Instat software for the Mac-
intosh (GraphPad, San Diego, CA) was used. For multiple
comparisons, analysis of variance using a Bonferroni cor-
rection for the number of comparisons was used. For
paired comparisons, a paired Student's T test was used. To
quantitate differences in images of protein or mRNA
expression, films were scanned and densitometry per-
formed using NIH Image 1.54 software.
Authors' contributions
MWM designed, performed the experiments, analyzed
data, and wrote the manuscript. YL and EBC conceived
and designed the experiments and revised the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
This work was supported by NIH grants DK-38510 and DK-47722 (EBC), 
the Digestive Disease Research Center of the University of Chicago (DK-
42086), and the Gastrointestinal Research Foundation of Chicago.
References
1. Drumm K, Kress TR, Gassner B, Krug AW, Gekle M: Aldosterone
stimulates activity and surface expression of NHE3 in human
primary proximal tubule epithelial cells (RPTEC).  Cell Physiol
& Biochem 2006, 17:21-28.
2. du Cheyron D, Chalumeau C, Defontaine N, Klein C, Kellermann O,
Paillard M, Poggioli J: Angiotensin II stimulates NHE3 activity by
exocytic insertion of the transporter: role of PI 3-kinase.  Kid-
ney Int 2003, 64:939-949.
3. Schelling JR, Linas SL: Angiotensin II-dependent proximal
tubule sodium transport requires receptor-mediated endo-
cytosis.  Am J Physiol 1994, 266:C669-C675.
4. Tsuganezawa H, Preisig PA, Alpern RJ: Dominant negative c-Src
inhibits angiotensin II induced activation of NHE3 in OKP
cells.  Kidney Int 1998, 54:394-398.
5. Efendiev R, Budu CE, Cinelli AR, Bertorello AM, Pedemonte CH:
Intracellular Na+ regulates dopamine and angiotensin II
receptors availability at the plasma membrane and their cel-
lular responses in renal epithelia.  J Biol Chem 2003,
278:28719-28726.
6. Horita S, Zheng Y, Hara C, Yamada H, Kunimi M, Taniguchi S, Uwa-
toko S, Sugaya T, Goto A, Fujita T, Seki G: Biphasic regulation of
Na+-HCO3- cotransporter by angiotensin II type 1A recep-
tor.  Hypertension 2002, 40:707-712.
7. Robey RB, Ruiz OS, Espiritu DJ, Ibanez VC, Kear FT, Noboa OA, Ber-
nardo AA, Arruda JA: Angiotensin II stimulation of renal epi-
thelial cell Na/HCO3 cotransport activity: a central role for
Src family kinase/classic MAPK pathway coupling.  J Membrane
Biol 2002, 187:135-145.
8. Zhou Y, Bouyer P, Boron WF: Role of the AT1A receptor in the
CO2-induced stimulation of HCO3- reabsorption by renal
proximal tubules.   Am J Physiol Renal Physiol 2007,
293(1):F110-F120.
9. Hatch M, Freel RW: Increased colonic sodium absorption in
rats with chronic renal failure is partially mediated by AT1
receptor agonism.  Am J Physiol Gastrointest Liver Physiol 2008,
295(2):G348-G356.
10. Wang Q, Horisberger JD, Maillard M, Brunner HR, Rossier BC,
Burnier M: Salt- and angiotensin II-dependent variations in
amiloride-sensitive rectal potential difference in mice.  Clin &
Exp Pharmacol & Physiol 2000, 27:60-66.
11. Jin XH, Wang ZQ, Siragy HM, Guerrant RL, Carey RM: Regulation
of jejunal sodium and water absorption by angiotensin sub-
type receptors.  Am J Physiol 1998, 275:R515-R523.
12. Levens NR: Control of intestinal absorption by the renin-angi-
otensin system.  Am J Physiol 1985, 249:G3-G15.
13. Levens NR: Response of isolated rat jejunum to angiotensin
peptides.  Am J Physiol 1986, 251:G559-G566.
14. Granquist L, Chen M, Gerasev A, Aizman R, Celsi G: Regulation of
K+ transport in rat distal colon via angiotensin II subtype
receptors and K+-pathways.  Acta Phys Scand 2001, 171:145-151.
15. Ewert S, Johansson B, Holm M, Helander HF, Fandriks L: The brady-
kinin BK2 receptor mediates angiotensin II receptor type 2
stimulated rat duodenal mucosal alkaline secretion.  BMC
Physiol 2003, 3:1.
16. Ewert S, Sjoberg T, Johansson B, Duvetorp A, Holm M, Fandriks LL:
Dynamic expression of the angiotensin II type 2 receptor and
duodenal mucosal alkaline secretion in the Sprague-Dawley
rat.  Exp Physiol 2006, 91:191-199.
17. Johansson B, Holm M, Ewert S, Casselbrant A, Pettersson A, Fandriks
L:  Angiotensin II type 2 receptor-mediated duodenal
mucosal alkaline secretion in the rat.  Am J Physiol Gastrointest
Liver Physiol 2001, 280:G1254-G1260.
18. Cox HM, Munday KA, Poat JA: Identification of selective, high
affinity [125I]-angiotensin and [125I]-bradykinin binding
sites in rat intestinal epithelia.  Br J Pharmacol 1986, 87:201-209.
19. Chiu T, Santiskulvong C, Rozengurt E: ANG II stimulates PKC-
dependent ERK activation, DNA synthesis, and cell division
in intestinal epithelial cells.  Am J Physiol 2003, 285:G1-G11.
20. Chiu T, Santiskulvong C, Rozengurt E: EGF receptor transactiva-
tion mediates ANG II-stimulated mitogenesis in intestinal
epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1
signaling pathway.  Am J Physiol 2005, 288:G182-G194.
21. Slice LW, Chiu T, Rozengurt E: Angiotensin II and epidermal
growth factor induce cyclooxygenase-2 expression in intesti-
nal epithelial cells through small GTPases using distinct sig-
naling pathways.  J Biol Chem 2005, 280:1582-1593.
22. Yun CH, Tse CM, Nath SK, Levine SA, Brant SR, Donowitz M: Mam-
malian Na+/H+ exchanger gene family: structure and func-
tion studies.  Am J Physiol 1995, 269:G1-G11.
23. Zachos NC, Tse M, Donowitz M: Molecular physiology of intes-
tinal Na+/H+ exchange.  Ann Review Physiol 2005, 67:411-443.
24. McSwine RL, Musch MW, Bookstein C, Xie Y, Rao MC, Chang EB:
Regulation of apical membrane Na+/H +exchangers NHE2
and NHE3 in intestinal epithelial cell line CACO-2BBE/bbe.
Am J Physiol 1998, 275:C693-C701.
25. Musch MW, Arvans DL, Walsh-Reitz MM, Uchiyama K, Fukuda M,
Chang EB: Synaptotagmin I binds intestinal epithelial NHE3
and mediates cAMP and Ca++-induced endocytosis by
recruitment of AP2 and clathrin.   Am J Physiol Gastrointest Liver
Physiol 2007, 292(6):G1549-G1588.
26. Cano A: Characterization of the rat NHE3 promoter.  Am J
Physiol 1996, 271:F629-F636.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Physiology 2009, 9:5 http://www.biomedcentral.com/1472-6793/9/5
Page 8 of 8
(page number not for citation purposes)
27. Rakotoarisoa L, Carricaburu V, Leblanc C, Mironneau C, Mironneau
J, Macrez N: Angiotensin II-induced delayed stimulation of
phospholipase C gamma1 requires activation of both phos-
phatidylinositol 3-kinase gamma and tyrosine kinase in vas-
cular myocytes.  J Cell Mol Med 2006, 10(3):734-748.
28. Henrion D, Kubis N, Levy BI: Physiological and pathophysiolog-
ical functions of the AT2 subtype receptor of angiotensin II:
From large arteries to the microcirculation.  Hypertension
2001, 38:1150-1157.
29. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Hohle
S, Meffert S, Stoll M, Stroth U, Zhu YZ: Angiotensin receptors.  J
Hyperten Suppl 1996, 14:S95-S103.
30. Coric T, Hernandez N, Alvarez de la Rosa D, Shao D, Wang T,
Canessa CM: Expression of ENaC and serum- and glucocorti-
coid-induced kinase 1 in the rat intestinal epithelium.  Am J
Physiol Gastrointest Liver Physiol 2004, 286:G663-G670.
31. Cho JH, Musch MW, Bookstein C, McSwine RL, Rabenau K, Chang
EB: Aldosterone stimulates intestinal Na+ absorption in rats
by increasing NHE3 expression of the proximal colon.  Am J
Physiol 1998, 274:C586-C594.
32. Yeo C, Barry K, Gontarek D, Donowitz M: Na+-H+ exchange
mediates meal-stimulated ileal absorption.  Surgery 1994,
116:338-394.
33. Wong TP, Debnam ES, Leung PS: Involvement of an enterocyte
renin-angiotensin system in the local control of SGLT1-
dependent glucose uptake across the rat small intestinal
brush border membrane.  J Physiol 2007, 584:613-623.
34. Kawano K, Ikari A, Nakano M, Suketa Y: Phosphatidyl inositol 3-
kinse mediates the inhibitory effect of angiotensin II on
sodium/glucose cotransporter in renal epithelial cells.  Life Sci
2002, 71:1-13.
35. Leung PS: The peptide hormone angiotensin II: its new func-
tions in tissues and organs.  Curr Protein Pept Sci 2004, 5:267-273.
36. Paul M, Poyan MA, Kreutz R: Physiology of local renin-angi-
otensin systems.  Physiol Rev 2006, 86:747-803.
37. Erickson RH, Suzuki Y, Sedlmayer A, Song IS, Kim YS: Rat intestinal
angiotensin-converting enzyme: purification, properties,
expression, and function.  Am J Physiol 1992, 263:G466-G473.
38. Naim HY: Angiotensin converting enzyme of the human small
intestine. Subunit and quarternary structure, biosynthesis
and membrane association.  Biochem J 1992, 286:451-457.
39. Seo MS, Fukamizu A, Saito Y, Murakami K: Identification of a pre-
viously unrecognized production site of human renin.  Biochim
Biophys Acta 1991, 1129:87-89.
40. Peterson MD, Mooseker MS: An in vitro model for the analysis
of intestinal brush border assembly. I. Ultrastructural analy-
sis of cell contact-induced brush border assembly in Caco-
2BBE cells.  J Cell Sci 1993, 105:445-460.
41. Bookstein C, DePaoli AM, Xie Y, Niu P, Musch MW, Rao MC, Chang
EB: Na+/H+ exchangers NHE1 and NHE3, of rat intestine.  J
Clin Invest 1994, 93:106-113.
42. Musch MW, Bookstein C, Xie Y, Sellin JH, Chang EB: SCFA
increase intestinal Na absorption by induction of NHE3 in
rat colon and human intestinal C2/bbe cells.   Am J Physiol Gas-
trointest Liver Physiol 2001, 280(4):G687-G693.
43. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed
MW:  Quantitative reverse transcription-polymerase chain
reaction to study mRNA decay: comparison of endpoint and
real time methods.  Anal Biochem 2000, 285:194-204.